[Not published yet] Covid-19 vaccine made by China’s Sinopharm has an efficacy rate of 72.5 percent
25 Feb, 2021 | 09:07h | UTCSee also: Sinopharm’s Wuhan unit reports 72.5% efficacy for COVID shot, seeks approval in China – Reuters
Commentary on Twitter
The Sinopharm unit Wuhan Institute Of Biological Products Co said on Wednesday its COVID-19 vaccine had shown an efficacy rate of 72.51% against the disease in Phase III clinical trials, based on interim analysis. https://t.co/YTmV8xzyhF
— Reuters Health (@Reuters_Health) February 24, 2021